Staple Line Inversion vs Buttressing on Postoperative Vomits After LSG

Sponsor
Hospital General Universitario Elche (Other)
Overall Status
Unknown status
CT.gov ID
NCT03104023
Collaborator
(none)
100
1
2
7
14.4

Study Details

Study Description

Brief Summary

Patients undergoing laparoscopic sleeve gastrectomy will be randomized into 2 groups. In one group, a staple line inversion with a running suture of Polypropylene will be performed. In the second group, the gastric section will be performed with a stapler with preloaded buttress material

Postoperative nausea and vomits during the first 24 hours will be investigated.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Staple line inversion
  • Combination Product: Staple line buttressing
Phase 3

Detailed Description

Patients undergoing laparoscopic sleeve gastrectomy as bariatric procedure will be randomized into 2 groups. In one group after the stapling and section of the stomach with stapling devices (EndoGIA, Covidien, USA), a staple line inversion with hemostatic and aims will be performed. Staple line inversion will be performed with a running suture of Polypropylene 2/0. In the second group, the gastric section will be performed with a stapler with preloaded buttress material (EndoGIA with reinforced reload, Covidien, USA).

Postoperative nausea and vomits during the first 24 hours after surgery will be investigated.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Influence of Staple Line Inversion vs Buttressing on Postoperative Nausea or Vomits After Laparoscopic Sleeve Gastrectomy (LSG)
Actual Study Start Date :
Jan 1, 2017
Anticipated Primary Completion Date :
Aug 1, 2017
Anticipated Study Completion Date :
Aug 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Staple line inversion

Patients will undergo a staple line inversion with a a running suture of Polypropylene 2/0.

Procedure: Staple line inversion
A staple line inversion will be performed with a running suture of Polypropylene 2/0

Experimental: Staple line buttressing

The gastric section will be performed with preloaded buttress material .

Combination Product: Staple line buttressing
The gastric section will be performed with a stapler with preloaded buttress material

Outcome Measures

Primary Outcome Measures

  1. Postoperative nausea and vomits [24 hours after surgery]

    Postoperative nausea and vomits will be measured using the postoperative nausea and vomiting intensity scale, described by Wengritzky et al (Br J Anaesth 2010;104:158-166). In this scale, the number of vomits are quantified, the frequence of nausea and if it is constant or varying are determined, and the duration of the feeling of nausea is established.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • BMI >40

  • BMI>35 with obesity-related comorbidities

Exclusion Criteria:
  • Patients undergoing other bariatric techniques than sleeve gastrectomy

  • Laparotomic approach

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital general Universitario de Elche Elche Alicante Spain 03202

Sponsors and Collaborators

  • Hospital General Universitario Elche

Investigators

  • Principal Investigator: Jaime Ruiz-Tovar, Hospital general Elche

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jaime Ruiz-Tovar, MD, PhD, Head of Bariatric Surgery Unit. Hospital general Elche, Hospital General Universitario Elche
ClinicalTrials.gov Identifier:
NCT03104023
Other Study ID Numbers:
  • HGUE 2016-33
First Posted:
Apr 7, 2017
Last Update Posted:
Jun 27, 2017
Last Verified:
Mar 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 27, 2017